Clinical Trial Update: Urea Cream Treatment Sorafenib-Associated HSFR in HCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical urea cream to treat sorafenib-associated hand-foot skin reaction in hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• Urea cream (urea cream)

Snippet

Sponsor: Chinese Anti-Cancer Association | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED